| Drug Name: | Prostaglandin (PG) E1 (CASNA00110) |
|---|---|
| PubChem ID: | |
| SMILES: | |
| InchiKey: | |
| Therapeutic Category: |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Atropine-Antagonized Miosis | Vasopressin V1a receptor (P37288) | The PGEs elicited pronounced@ atropine-antaGOnized miosis and an inhibition of the water diuresis accompanied by some increase in renal excretion of arginine vasopressin (AVP) [ ADR Type 1 ] | Atropine-antaGOnized miosis induced in the GOat by intravenous infusions of prostaglandin E (PGE1 and PGE2) |
| Miosis | Vasopressin V1a receptor (P37288) | Endotoxin-induced miosis and stimulation of AVP secretion previously demonstrated in the GOat might well have been secondary to systemic PGE production by intravenous infusions of prostaglandin E (PGE1 and PGE2) [ ADR Type 1 ] | Atropine-antaGOnized miosis induced in the GOat by intravenous infusions of prostaglandin E (PGE1 and PGE2) |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|